Revita Life Sciences

Research and Publications

  • A prospective, multicentric, randomized, open-label clinical trial to assess the safety and therapeutic efficacy of adult stem cells from bone marrow via various routes of administration in treating patients with complete spinal cord injury.
  • An interventional, non-randomized, open-label proof-of-concept study employing a multimodal approach in cases of brain death resulting from traumatic brain injury with diffuse axonal injury.
  • Crown Publishers USA releases a book series titled “PRP Application in Elbow, Knee & Shoulder” focusing on the therapeutic use of platelet-rich plasma.
  • Case-series documenting the reversal of methanol-induced blindness using autologous bone marrow-derived stem cells.
  • Investigating the therapeutic potential of bone marrow-derived stem cells in treating patients with methanol-induced blindness.
  • Utilizing adipose-derived stromal cells (stromal vascular fraction) and platelet-rich plasma via intra-articular injection for osteoarthritis treatment in the knee.
  • Investigating the efficacy of autologous bone marrow-derived stem cells in spinal cord injury treatment.
  • Proof-of-concept study assessing the effectiveness of autologous bone marrow-derived stem cell administration for treating cerebral palsy patients.
  • A brief study report on bone marrow aspirate concentrate cell therapy in ten South Asian Indian patients with autism.
  • Assessment of bone marrow processing protocol for therapeutic use through culture and characterization of Mesenchymal Stem Cells.
  • Treatment with autologous bone marrow-derived adult stem cells in quadriparesis caused by motor neuron disease.
  • Exploring the effects of stromal cell and bone marrow stem cell fusion in patients with mild Alzheimer’s disease in a proof-of-concept study.
  • Evaluation of intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy.
  • Editorial discussing autologous bone marrow transplantations in neurological disorders.
  • Utilizing new locked nails for intramedullary fixation of forearm fractures.
  • Investigating chondroprotection using a naturally occurring mineral supplementation formulation in degenerative knee osteoarthritis.
  • A randomized placebo-controlled clinical trial assessing the early relief provided by natural minerals used as a food supplement in osteoarthritis of the knees.
  • Exploring the critical dosage of Platelet-Rich Plasma (PRP) for long-term clinical efficacy in knee osteoarthritis.
  • Comparing the efficacy of PRP injection versus corticosteroid for pain relief and healing in shoulder pain.
  • Assessing the superiority of PRP injection over corticosteroid for pain relief and healing in knee pain.
  • Investigating the efficacy of PRP injection compared to corticosteroid for pain relief and healing in tennis elbow pain.
  • Exploring Platelet-Rich Plasma as a regenerative orthobiological tool.

Revita Life Sciences values each patient’s uniqueness, providing tailored treatment plans for optimal, targeted care and support.

Office Hours

Daily – 9:30 am to 6:30 pm

Sunday – 08:00 am to 11:30 am

Holidays – 08:00 am to 3:00 pm

Contact Info

HB Specialty Hospital & Research Institute, Near Bhoorarani Gate, Kashipur Road, Rudrapur, Udham Singh Nagar, Uttarakhand, India 263153

+915944240234 +919897080188

Copyright © 2024. All Rights Reserved.